Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (CAMP) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: a prospective study.

MLA

Trovò, M. G., et al. “Combined Radiotherapy and Chemotherapy with Cyclophosphamide, Adriamycin, Methotrexate, Procarbazine (CAMP) in 64 Consecutive Patients with Epidermoid Bronchogenic Carcinoma, Limited Disease: A Prospective Study.” International Journal of Radiation Oncology, Biology, Physics, vol. 8, no. 6, June 1982, pp. 1051–54. EBSCOhost, https://doi.org/10.1016/0360-3016(82)90176-6.

APA

Trovò, M. G., Tirelli, U., De Paoli, A., Franchin, G., Roncadin, M., Magri, M., Galligioni, E., Veronesi, A., Tumolo, S., Carbone, A., & Grigoletto, E. (1982). Combined radiotherapy and chemotherapy with cyclophosphamide, adriamycin, methotrexate, procarbazine (CAMP) in 64 consecutive patients with epidermoid bronchogenic carcinoma, limited disease: a prospective study. International Journal of Radiation Oncology, Biology, Physics, 8(6), 1051–1054. https://doi.org/10.1016/0360-3016(82)90176-6

Chicago

Trovò, M G, U Tirelli, A De Paoli, G Franchin, M Roncadin, M Magri, E Galligioni, et al. 1982. “Combined Radiotherapy and Chemotherapy with Cyclophosphamide, Adriamycin, Methotrexate, Procarbazine (CAMP) in 64 Consecutive Patients with Epidermoid Bronchogenic Carcinoma, Limited Disease: A Prospective Study.” International Journal of Radiation Oncology, Biology, Physics 8 (6): 1051–54. doi:10.1016/0360-3016(82)90176-6.